N-ras protein: Frequent quantitative and qualitative changes occur in human colorectal carcinomas

International Journal of Cancer

Volumn 71, Issue 5, 1997, Pages 767-775

  Kim, Kwonseop ^a   Kuo, Tom ^a   Cai, Jinguo ^a   Shuja, Sania ^a,b   Murnane, Mary Jo ^a,b  

^a BOSTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b BOSTON MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ONCOPROTEIN;

ANTIGEN EXPRESSION; ARTICLE; COLORECTAL CARCINOMA; CONTROLLED STUDY; GENE MUTATION; HUMAN; HUMAN TISSUE; MAJOR CLINICAL STUDY; ONCOGENE N RAS; PRIORITY JOURNAL;

ANTIBODIES, MONOCLONAL; BLOTTING, WESTERN; COLORECTAL NEOPLASMS; GENE EXPRESSION; GENES, RAS; HUMANS; INTESTINAL MUCOSA; POINT MUTATION; RAS PROTEINS;

EID: 0030949237     PISSN: 00207136     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1097-0215(19970529)71:5<767::AID-IJC13>3.0.CO;2-5     Document Type: Article

References (35)

1. BALLESTER, R., FURTH, M.E. and ROSEN, O.M., Phorbol ester-and protein kinase C-mediated phosphorylation of the cellular Kirsten ras gene product. J. biol Chem., 262, 2688-2695 (1987).
2. BOGUSKI, M.S. and MCCORMICK, F., Proteins regulating Ras and its relatives. Nature (Lond.), 366, 643-654 (1993).
3. BOS, J.L., ras oncogenes in human cancer: a review. Cancer Res., 49, 4682-4689 (1989).
4. BOS, J.L., FEARON, E.R., HAMILTON, S.R., VERLAAN-DEVRIES, M., VAN BOOM, J.H., VAN DER EB, A.J. and VOGELSTEIN, B., Prevalence of ras gene mutations in human colorectal cancers. Nature (Lond.), 327, 293-297 (1987).
5. CARBONE, A., GUSELLA, G.L., RADZIOCH, D. and VARESIO, L., Human Harvey-ras is biochemically different from Kirsten-or N-ras. Oncogene, 6, 731-737 (1991).
6. COHEN, J.B., BROZ, S.D. and LEVINSON, A.D., Expression of the H-ras proto-oncogene is controlled by alternative splicing. Cell, 58, 461-472 (1989).
7. COLEMAN, W.B., THRONEBURG, D.B., GRISHAM, J.W. and SMITH, G.J., Overexpression of c-Ki-ras, c-N-ras and transforming growth factor β co-segregate with tumorigenicity in morphologically transformed C3H 10T1/2 cell lines. Carcinogenesis, 15, 1005-1012 (1994).
8. COX, A.D. and DER, C.J., The Ras/cholesterol connection: implications for ras oncogenicity. Crit. Rev. Oncogenesis, 3, 365-400 (1992).
9. EGAN, S.E., BROERE, J.J., JAROLIM, L., WRIGHT, J.A. and GREENBERG, A.H., Co-regulation of metastatic and transforming activity of normal and mutant ras genes. Int. J. Cancer. 43, 443-448 (1989).
10. EGAN, S.E. and WEINBERG, R.A., The pathway to signal achievement. Nature (Lond.), 365, 781-783 (1993).
11. FURTH, M.E., ALDRICH, T.H. and CORDON-CARDO, C., Expression of ras proto-oncogene proteins in normal human tissues. Oncogene, 1, 47-58 (1987).
12. GULBIS, B., ALEXANDRE, K. and GALAND, P., Quantitative and/or qualitative changes in the p21-H-ras post-translational products in regenerating liver and during hepatocarcinogenesis. Int. J. Cancer, 55, 837-840 (1993).
13. GULBIS, B. and GALAND, P., Immunodetection of the p21-ras products in human normal and preneoplastic tissues and solid tumors: a review. Human Pathol., 24, 1271-1285 (1993).
14. GUTIERREZ, L., MAGEE, A.I., MARSHALL, C.J. and HANCOCK, J.F., Post-translational processing of p21ras is two step and involves carhoxyl-methylation and carboxy-terminal proteolysis. EMBO J., 8, 1093-1098 (1989).
15. HUANG, S. and AXELROD, D.E., Altered post-translational processing of p21ras oncoprotein in a transformation-suppressed cell line. Oncogene, 6, 1211-1218 (1991).
16. JANSSON, D.S., RADOSEVICH, J.A., CARNEY, W.P., ROSEN, S.T., SCHLOM, J., STAREN, E.D., HYSER, M.J. and GOULD, V.E., An immunohistochemical analysis of ras oncogene expression in epithelial neoplasms of the colon. Cancer. 65, 1329-1337 (1990).
17. JEFFERS, M. and PELLICER, A., Identification of multiple promoters within the N-ras proto-oncogene. Biochim. biophys. Acta, 1219, 623-635 (1994).
18. JONES, P.L., O'HARE, BASS, R.A., HEMSTREET, G.P. and HURST, R.E., Quantitative immunofluorescence anti-ras p21 antibody specificity, and cellular oncoprotein levels. Biochem. biophys. Res. Comm., 167, 464-470 (1990).
19. JOYCE, A.D., D'EMILIA, J.C., STEELE, G., LIBERTINO, J.A., SILVERMAN, M.L. and SUMMERHAYES, I.C., Detection of altered H-ras proteins in human tumors using Western blot analysis. Lab. Invest. 61, 212-218 (1989).
20. KINSELLA, A.R., MITCHELL, E.L., GUO, Y., FOX, M. and SCOTT, D., Introduction of the activated N-ras oncogene into human fibroblasts by retroviral vector induces morphological transformation and tumorigenicity. Carcinogenesis, 11, 1803-1809 (1990).
21. LEON, J., GUERRERO, I. and PELLICER, A., Differential expression of the ras gene family in mice. Mol. cell. Biol., 7, 1535-1540 (1987).
22. LOWE, P.N., PAGE, M.J., BRADLEY, S., RHODES, S., SYDENHAM, M., PATERSON, H. and SKINNER, R.H., Characterization of recombinant human Kirsten-ras(4B) p21 produced at high levels in Escherichia coli and insect baculovirus expression systems. J. biol. Chem., 266, 1672-1678 (1991).
23. LOWRY, O., ROSKBROUGH, N.J., FARR, A.L. and RANDALL, R.J., Protein measurement with the Folin phenol reagent. J. biol. Chem., 193, 265-275 (1951).
24. MIZUKAMI, Y. NOMOMURA, A., MICHIGISHI, T., NOGUCHI, M., NAKAMURA, S. and HASHIMOTO, Differential (Ha-, K-and N-) ras p21 expression in benign and malignant human thyroid tumors: an immunohistochemical study. Anticancer Res., 15, 755-759 (1995).
25. NAGAI, M.A., HABR-GAMA, A., OSHIMA, C.T.F. and BRENTANI, M.M., Association of genetic alterations of c-myc, c-fos and c-Ha-ras protooncogenes in colorectal tumors. Dis. Colon Rectum. 35, 444-451 (1992).
26. PALEJWALA, S. and GOLDSMITH, L.T., Ovarian expression of cellular Ki-ras p21 varies with physiological status. Proc. nat. Acad. Sci. (Wash.), 89, 4202-4206 (1992).
27. PLATZ, A., RINGBORG, U., GRAFSTROM, E., HOOG, A. and LAGERLOF, B., Immunohistochemical analysis of the N-ras p21 and the p53 proteins in naevi, primary tumours and metastases of human cutaneous malignant melanoma: increased immunopositivity in hereditary melanoma. Melanoma Res., 5, 101-106 (1995).
28. RAMAEL, M., DEBLIER, I., EERDEKENS, C., LEMMENS, G., JACOBS, W. and VAN MARCK, E., Immunohistochemical staining of ras oncogene product in neoplastic and non-neoplastic mesothelial tissues: immunoreactivity for N-ras and lack of immunohistochemical staining for Ha-ras and K-ras. J. Pathol., 169, 421-424 (1993).
29. ras membrane association by dehydroepiandrosterone in human colonic adenocarcinoma cells in vitro. Cancer Res., 51, 6563-6567 (1991).
30. +)-ATPase activity and cisplatin sensitivity between transformants induced by H-ras and those induced by K-ras. Int. J. Cancer, 58, 672-677 (1994).
31. THEODORESCU, D., CORNIL, I., FERNANDEZ, B.J. and KERBEL, R.S., Overexpression of normal and mutated forms of HRAS induces orthotopic bladder invasion in a human transitional cell carcinoma. Proc. nat. Acad. Sci. (Wash.), 87, 9047-9051 (1990).
32. TURNBULL, R.B., KYLE, K., WATSON, F.R. and SPRATT, J., Cancer of the colon. Ann. Surg., 166, 420-427 (1967).
33. UMANOFF, H., EDELMANN, W., PELLICER, A. and KUCHERLAPATI, R., The murine N-ras gene is not essential for growth and development. Proc. nat. Acad. Sci. (Wash.), 92, 1790-1713 (1995).
34. WILSON, D.M., YANG, D., DILLBERGER, J.E., DIETRICH, S.E., MAHER, V.M. and MCCORMICK, J.J., Malignant transformation of human fibroblasts by a transfected N-ray oncogene. Cancer Res., 50, 5587-5593 (1990).
35. ras monoclonal antibodies on Western blots. J. Immunol. Methods, 168, 275-282 (1994).